Insider Transactions in Q3 2025 at Harmony Biosciences Holdings, Inc. (HRMY)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2025
|
Sandip Kapadia CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
24,039
-53.42%
|
$649,053
$27.56 P/Share
|
|
Sep 30
2025
|
Sandip Kapadia CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
45,000
+50.0%
|
-
|
|
Aug 28
2025
|
Valor Iv Pharma Holdings, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
6,618,033
-100.0%
|
-
|
|
Aug 15
2025
|
Sandip Kapadia CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
21,573
-100.0%
|
$776,628
$36.5 P/Share
|